🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
The purpose is to determine the safety, effectiveness and best dose to use ...
Status
Completed
Location
City Of Hope
Start Date
2012-02-09
Trial ID
NCT01472081
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
This research is being done to assess the effectiveness and safety of the c...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-02-14
Trial ID
NCT04119336
Treatments Being Tested
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
The purpose of this study is to investigate the characteristics of tumors i...
Status
Completed
Location
University of Connecticut Health Center
Start Date
2015-09-14
Trial ID
NCT02553642
Treatments Being Tested
A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center - Dallas
Start Date
2018-03-01
Trial ID
NCT03126461
Treatments Being Tested
Melanoma is the deadliest form of skin cancer and its incidence has doubled...
Status
Completed
Location
Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS
Start Date
2019-08-16
Trial ID
NCT03949153
Treatments Being Tested
Patients with malignant pleural mesothelioma stage I-III who have undergone...
Status
Completed
Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Start Date
2019-02-04
Trial ID
NCT04177953
Treatments Being Tested
The PRINCESS study is a hypothesis-generating, interventional, open-label, ...
Status
Unknown
Location
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Start Date
2021-12-02
Trial ID
NCT05821751
Treatments Being Tested